Novan Inc (NOVN.OQ)
Get access to over 18 million research reports from over 1,700 sources.
For several years, Reuters.com has provided analyst research reports for downloading. In an effort to streamline our website, analyst research will now be available from our dedicated page for Thomson Reuters On Demand, and the Reuters service will discontinue as of September 30, 2016.
Thomson Reuters On Demand provides over 18 million research reports from 1,700 sources.
Moreover, Thomson Reuters On Demand offers fast and cost-effective solutions that would allow you to retrieve information on:
- private equity
- third-party document and information retrieval
- and much, much more…
Click here to request a report and the team of expert analysts will get back to you shortly, to ensure you get the report you need.
|74||2011||Independent Chairman of the Board|
|36||2017||President, Chief Scientific Officer, Director|
|57||2017||Interim Chief Executive Officer, Director|
|2018||Chief Business Officer, Interim Chief Financial Officer and Principal Financial Officer|
|2017||Senior Vice President - Research and Development|
- BRIEF-Novan Provides Update On SB414 Inflammatory Skin Disease Development Program
- BRIEF-Novan Interim CEO Kelly Martin Will No Longer Serve In Interim Capacity
- BRIEF-Eugene Sun Appointed To Novan Board Of Directors
- BRIEF-Novan Announces First Patient Dosed In Phase 2 Molluscum Contagiosum Trial With SB206
- BRIEF-Reedy Creek Investments Reports 26.4 Percent Stake In Novan Inc